No Data
No Data
Express News | Processa Pharmaceuticals Appoints Russell L. Skibsted As CFO
Express News | Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer
H.C. Wainwright Maintains Processa Pharmaceuticals(PCSA.US) With Buy Rating, Maintains Target Price $8
Express News | Processa Pharmaceuticals Shares Are Trading Higher After the Company Announced Efficacy Results From a Preliminary Evaluation of Its Phase 1b Dose-escalating Trial With NGC-Cap in Gastrointestinal Cancer
Express News | Processa Pharmaceuticals - Preliminary Analysis of Efficacy Data Showed Early Evidence of Anti-Tumor Activity of Capecitabine Combined With Pcs6422
Express News | Processa Pharmaceuticals Inc - Eight of 12 Evaluable Patients (66.7%) Had Progression-Free Survival (Pfs) Ranging From 5 to 11 Months
No Data